Mismatch of minor histocompatibility antigen contributes to a graft-versus-leukemia effect rather than to acute GVHD, resulting in long-term survival after HLA-identical stem cell transplantation in Japan

Bone Marrow Transplantation

Volumn 38, Issue 10, 2006, Pages 681-686

  Katagiri, T ^a   Shiobara, S ^b   Nakao, S ^c   Wakano, M ^a   Muranaka, E ^a   Kuba, N ^b   Furukawa, T ^d   Tsukada, J ^e   Takeda, H ^d   Aizawa, Y ^f   Harada, M ^g  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^c KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^d NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^e UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^f NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^g KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTEGRIN; CD31 ANTIGEN; CELL ADHESION MOLECULE; CYCLOSPORIN A; HLA ANTIGEN CLASS 1; L SELECTIN; METHOTREXATE; MINOR HISTOCOMPATIBILITY ANTIGEN; PADGEM PROTEIN; TACROLIMUS; VERY LATE ACTIVATION ANTIGEN 2;

ACUTE GRAFT VERSUS HOST DISEASE; ALLELE; ARTICLE; CANCER SURVIVAL; CHRONIC GRAFT VERSUS HOST DISEASE; CODON; CONTROLLED STUDY; FEMALE; FREQUENCY ANALYSIS; GENETIC POLYMORPHISM; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; JAPAN; LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; PROBABILITY; RECURRENCE RISK; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME; WHOLE BODY RADIATION;

ACUTE DISEASE; BASE SEQUENCE; DNA PRIMERS; FEMALE; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HLA ANTIGENS; HUMANS; JAPAN; LEUKEMIA; MALE; MINOR HISTOCOMPATIBILITY ANTIGENS; RECURRENCE; STEM CELL TRANSPLANTATION; SURVIVAL RATE;

EID: 33750573506     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705506     Document Type: Article

References (19)

1. Den Haan JM, Sherman NE, Blokland E, Huczko E, Koning F, Drijfhout JW et al. Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 1995; 268: 1476-1480.
2. Goulmy E, Schipper R, Pool J, Blokland E, Falkenburg JH, Vossen J et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 1996; 334: 281-285.
3. Tseng LH, Lin MT, Hansen JA, Gooley T, Pei J, Smith AG et al. Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus host disease after allogeneic bone marrow transplantation. Blood 1999; 94: 2911-2914.
4. Dickinson AM, Wang XN, Sviland L, Vyth-Dreese FA, Jedtson GH, Schmacher TN et al. In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens. Nat Med 2002; 8: 410-414.
5. Mutis T, Verdijk R, Schrama E, Esendam B, Brand A, Goulmy E et al. Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens. Blood 1999; 93: 2336-2341.
6. Maruya E, Saji H, Seki S, Fujii Y, Kato K, Kai S et al. Evidence that CD31, CD49b and CD62L are immunodominant minor histocompatibility antigens in HLA identical sibling bone marrow transplants. Blood 1998; 92: 2169-2176.
7. Behar E, Chao NJ, Hiraki DD, Krishaswany S, Brown BW, Zehnder JL et al. Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease. N Engl J Med 1996; 334: 286-291.
8. Grumet FC, Hiraki DD, Brown BWM, Zehnder JL, Zacks ES, Drasksharapu A et al. CD31 mismatching affects marrow transplantation outcome. Biol Blood Marrow Transplant 2001; 7: 503-5122.
9. Balduiri CL, Frassoni F, Noris P, Klersy C, Iannore AM, Bacigulupo A et al. Donor-recipient incompatibility at CD31-codon 563 is a major factor for acute graft-versus-host-disease after allogeneic bone marrow transplantation from a human leukocytes antigen-matched donor. Br J Haematol 2001; 114: 951-953.
10. Shiobara S, Nakao S, Ueda M, Yamazaki H, Takahashi S, Asano S et al. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: Lower incidence of acute graft versus host disease and improved outcome. Bone Marrow Transplant 2000; 26: 769-774.
11. Morishima Y, Kodera Y, Hirabayashi N, Tanimoto M, Matsuyama T, Horibe K et al. Low incidence of acute GVHD in patients transplanted with marrow from HLA-A, B, DR-compatible unrelated donors among Japanese. Bone Marrow Transplant 1995; 15: 235-239.
12. Kodera Y, Morishima Y, Kato S, Akiyama Y, Sao H, Matsuyama T et al. Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: Confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia. Bone Marrow Transplant 1999; 24: 995-1003.
13. Sidney J, Grey HM, Kubo RT, Sette A. Practical, biochemical and evolutionary implications of the discovery of HLA Class I supermotifs. Immunol Today 1996; 17: 261-265.
14. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 consensus conference on acute GVHD grade. Bone Marrow Transplant 1995; 15: 825-828.
15. Murata M, Emi N, Hirabayashi N, Hamaguchi M, Goto S, Wakita A et al. No significant between HA-1 incompatibility and incidence of acute graft-versus-host-disease after HLAidentical sibling bone marrow transplantation in Japanese patients. Int J Hematol 2000; 72: 371-375.
16. Oh H, Loberiza Jr FR, Zhang MJ, Ringden O, Akiyama H, Asai T et al. Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations. Blood 2005; 105: 1408-1416.
17. Morishima Y, Morishita Y, Tanimoto M, Ohno R, Saito H, Horibe K et al. Low incidence of acute graft-versus-host disease by administration of methotrexate and cyclosporin in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings: possible role of genetic homogeneity. The Nagoya Bone Marrow Transplantation Group. Blood 1995; 74: 2252-2256.
18. Fleischhauer K, Tanzarella S, Wallny HJ, Bordignon C, Traversari C. Multiple HLA-A alleles can present an immunodominant peptide of the human melanoma antigen Melan-A/MART-1 to a peptide-specific HLA-A*0201+cytotoxic T cell line. J Immunol 1996; 157: 787-797.
19. Threlkeld SC, Wentworth PA, Kalams SA, Wilkes BM, Ruhl DJ, Keogh E et al. Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily: Implications for vaccine development. J Immunol 1997; 159: 1648-1657.